Group One Trading
SIOX

Group One Trading’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Group One Trading’s Portfolio SIOX Stock Details SIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,300
Closed -$1K – 8398
2022
Q3 		$1K Sell
2,300
-1,300
-36% -$446 ﹤0.01% 7429
2022
Q2 		$1K Sell
3,600
-18,800
-84% -$7.78K ﹤0.01% 7680
2022
Q1 		$15K Sell
22,400
-40,100
-64% -$34K ﹤0.01% 6975
2021
Q4 		$81K Sell
62,500
-23,000
-27% -$40.8K ﹤0.01% 5917
2021
Q3 		$186K Buy
85,500
+4,800
+6% +$10.4K ﹤0.01% 5254
2021
Q2 		$220K Buy
80,700
+53,600
+198% +$133K ﹤0.01% 5152
2021
Q1 		$71K Sell
27,100
-272,600
-91% -$771K ﹤0.01% 5957
2020
Q4 		$833K Buy
299,700
+272,100
+986% +$792K ﹤0.01% 2814
2020
Q3 		$128K Buy
27,600
+23,700
+608% +$78.2K ﹤0.01% 4012
2020
Q2 		$11K Buy
3,900
+3,400
+680% +$10.9K ﹤0.01% 5101
2020
Q1 		$1K Sell
500
-15,000
-97% -$54.2K ﹤0.01% 5138
2019
Q4 		$79K Sell
15,500
-100
-0.6% -$555 ﹤0.01% 3785
2019
Q3 		$101K Sell
15,600
-52,600
-77% -$363K ﹤0.01% 3550
2019
Q2 		$425K Buy
68,200
+63,875
+1,477% +$486K ﹤0.01% 2272
2019
Q1 		$46K Sell
4,325
-525
-11% -$5.23K ﹤0.01% 3611
2018
Q4 		$39K Sell
4,850
-33,938
-87% -$489K ﹤0.01% 3680
2018
Q3 		$751K Buy
38,788
+18,063
+87% +$329K 0.01% 1927
2018
Q2 		$375K Buy
20,725
+11,437
+123% +$169K ﹤0.01% 2544
2018
Q1 		$99K Sell
9,288
-12,187
-57% -$196K ﹤0.01% 3252
2017
Q4 		$905K Sell
21,475
-8,263
-28% -$371K 0.01% 1792
2017
Q3 		$1.64M Buy
29,738
+21,475
+260% +$3.62M 0.01% 1204
2017
Q2 		$1.53M Buy
8,263
+4,738
+134% +$831K 0.02% 1133
2017
Q1 		$421K Buy
3,525
+2,912
+475% +$305K ﹤0.01% 1963
2016
Q4 		$61K Sell
613
-587
-49% -$61.8K ﹤0.01% 3150
2016
Q3 		$134K Sell
1,200
-800
-40% -$96K ﹤0.01% 2754
2016
Q2 		$205K Hold
2,000
– – ﹤0.01% 2389
2016
Q1 		$184K Sell
2,000
-25
-1% -$2.67K ﹤0.01% 2379
2015
Q4 		$292K Sell
2,025
-3,963
-66% -$516K ﹤0.01% 2223
2015
Q3 		$619K Buy
+5,988
New +$702K 0.01% 1606

Other funds holding SIOX

JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
CIA
Cladis Investment Advisory Billings, Montana $182M AUM 33.3% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return

Group One Trading's SIOX Position: Q1 2023 in Review

Group One Trading sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q1 2023, closing a stake of 902 shares — an estimated $392 sold.

Group One Trading first reported a position in SIOX in Q4 2015 and held it in 25 quarters. The position peaked at $2.07M in Q3 2017. 4 funds tracked by Wall St. Rank hold SIOX as of Q1 2023.

  • Group One Trading reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Group One Trading sold 902 Sio Gene Therapies Inc. Common Stock shares in Q1 2023, an estimated $392.
  • Group One Trading first reported a position in Sio Gene Therapies Inc. Common Stock in Q4 2015 and held it in 25 quarters.
  • Group One Trading's Sio Gene Therapies Inc. Common Stock position peaked at $2.07M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q1 2023.

Based on Group One Trading's 13F filing for Q1 2023, filed 12 May 2023.